CellCarta (formerly known as Caprion-HistoGeneX) is a contract research organization (CRO) with expertise in immune monitoring, proteomics, and biomarker research. It offers testing services, including biomarker solutions, immune monitoring, proteomics, genomics, histopathology, data analysis, and regulatory expertise as well as related software and sample logistics and clinical site training services. The company's therapeutic areas include oncology, infectious diseases, immunology, and neurosciences.